Engraftment syndrome after autologous peripheral blood stem cell transplantation with high numbers of peripheral blood stem cells followed by granulocyte colony-stimulating factor administration.
Kawano
C
C
Muroi
K
K
Kuribara
R
R
Matsumoto
Y
Y
Ohtsuki
T
T
Hatake
K
K
Ozawa
K
K
D018952:Antigens, CD34 / Q000032:analysis; D001804:Blood Transfusion, Autologous / Q000009:adverse effects; D003131:Combined Modality Therapy; D005260:Female; D016179:Granulocyte Colony-Stimulating Factor / Q000008:administration & dosage / Q000009:adverse effects*; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D006412:Hematopoietic Stem Cells / Q000737:chemistry / Q000166:cytology*; D006801:Humans; D007958:Leukocyte Count; D008875:Middle Aged; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000150:complications* / Q000628:therapy*; D013577:Syndrome; D016896:Treatment Outcome
D018952:Antigens, CD34; D016179:Granulocyte Colony-Stimulating Factor